companydata.dkcompanydata.dk

AVP BioPharma Consult ApS: Financial statements 2024

CVR: 37770426

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,169,184 and a net result of DKK 237,789 compared with DKK 106,199 the year before. That is an increase of 15.9% compared with the year before. Equity in the 2024 report amounted to DKK 323,077. The solvency ratio was 64%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,169,184
Profit/Loss
DKK 237,789
Equity
DKK 323,077
Total Assets
DKK 504,450
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.2M238K323K1
2023-1M106K225K1
2022-1.1M148K294K1
2021-1.2M261K346K1
2020-1.1M190K295K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

AVP BioPharma Consult ApS: The 2023 annual report is outApr 12, 2024

AVP BioPharma Consult ApS has published its annual report for 2023. Gross profit came to DKK 1,008,640, and the net result was DKK 106,199.

About AVP BioPharma Consult ApS

AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.

Source: annual report 2025, Danish Business Authority